Evidence map›Paper›PMID 26539169›Full record

ArticleFrontiers in microbiology2015

Discovery of novel small molecule modulators of Clavibacter michiganensis subsp. michiganensis.

Xiulan Xu, Anand Kumar, Loïc Deblais, Ruby Pina-Mimbela, Corey Nislow, James R Fuchs, Sally A Miller, Gireesh Rajashekara

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Deletion ofInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Biocontrol RhizobacteriumFrontiers in microbiology · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiulan XuDepartment of Plant Pathology, Ohio Agricultural Research and Development Center, The Ohio State University Wooster, OH, USA.
Anand KumarFood Animal Health Research Program, Department of Veterinary Preventive Medicine, The Ohio State University Wooster, OH, USA.
Loïc DeblaisFood Animal Health Research Program, Department of Veterinary Preventive Medicine, The Ohio State University Wooster, OH, USA.
Ruby Pina-MimbelaFood Animal Health Research Program, Department of Veterinary Preventive Medicine, The Ohio State University Wooster, OH, USA.
Corey NislowPharmaceutical Sciences, University of British Columbia Vancouver, BC, Canada.
James R FuchsCollege of Pharmacy, The Ohio State University Columbus, OH, USA.
Sally A MillerDepartment of Plant Pathology, Ohio Agricultural Research and Development Center, The Ohio State University Wooster, OH, USA.
Gireesh RajashekaraFood Animal Health Research Program, Department of Veterinary Preventive Medicine, The Ohio State University Wooster, OH, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clavibacter michiganensis subsp. michiganensis (Cmm) is a Gram-positive seed-transmitted bacterial phytopathogen responsible for substantial economic losses by adversely affecting tomato production worldwide. A high-throughput, cell-based screen was adapted to identify novel small molecule growth inhibitors to serve as leads for future bactericide development. A library of 4,182 compounds known to be bioactive against Saccharomyces cerevisiae was selected for primary screening against Cmm wild-type strain C290 for whole-cell growth inhibition. Four hundred sixty-eight molecules (11.2% hit rate) were identified as bacteriocidal or bacteriostatic against Cmm at 200 μM. Seventy-seven candidates were selected based on Golden Triangle analyses for secondary screening. Secondary screens showed that several of these candidates were strain-selective. Several compounds were inhibitory to multiple Cmm strains as well as Bacillus subtilis, but not to Pseudomonas fluorescens, Mitsuaria sp., Lysobacter enzymogenes, Lactobacillus rhamnosus, Bifidobacterium animalis, or Escherichia coli. Most of the compounds were not phytotoxic and did not show overt host toxicity. Using a novel 96-well bioluminescent Cmm seedling infection assay, we assessed effects of selected compounds on pathogen infection. The 12 most potent novel molecules were identified by compiling the scores from all secondary screens combined with the reduction of pathogen infection in planta. When tested for ability to develop resistance to the top-12 compounds, no resistant Cmm were recovered, suggesting that the discovered compounds are unlikely to induce resistance. In conclusion, here we report top-12 compounds that provide chemical scaffolds for future Cmm-specific bactericide development.

Indexed as

bioluminescent imagingCmmhigh throughput screeningsmall molecule inhibitorstomato canker

Identifiers

PMID26539169
PMCPMC4609890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.